Fate Therapeutics Inc (FATE) SEC filings
FATENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3016% above fair value
$1.28−0.06 (-4.48%)
Close on Nov 13, 2026Market cap $153.37MP/E –Yield –
SEC filings
40 of Fate Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Nov 5, 2026 | Nov 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2026 | Nov 5, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 25, 2026 | Sep 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2026 | Jun 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2026 | Apr 24, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2026 | Feb 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 26, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2025 | Aug 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | May 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 29, 2025 | Apr 17, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2024 | Jan 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 27, 2024 | Nov 29, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2024 | Nov 12, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2024 | Aug 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 13, 2024 | Aug 13, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2024 | Jul 31, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 7, 2024 | Jun 10, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2024 | Jun 7, 2024 | SEC EDGAR |
| Current report | 8-K | May 30, 2024 | May 31, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Current report | 8-K | May 9, 2024 | May 9, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 7, 2024 | Apr 26, 2024 | SEC EDGAR |
See a number that looks wrong?